Abstract:BackgroundAlthough the whole tumor cell vaccine can provide the best source of immunizing antigens, there is still a limitation that most tumors are not naturally immunogenic. Tumor cells genetically modified to secrete immune activating cytokines have been proved to be more immunogenic. IL-18 could augment proliferation of T cells and cytotoxicity of NK cells. GM-CSF could stimulate dendritic cells, macrophages and enhance presentation of tumor antigens. In our study, we used mouse GM-CSF combined with IL-18 to modify Lewis lung cancer LL/2, then investigated whether vaccination could suppress tumor growth and promote survival.MethodsThe Lewis lung cancer LL/2 was transfected with co-expressing mouse GM-CSF and IL-18 plasmid by cationic liposome, then irradiated with a sublethal dose X ray (100 Gy) to prepare vaccines. Mice were subcutaneously immunized with this inactivated vaccine and then inoculated with autologous LL/2 to estimate the antitumor efficacy.ResultsThe studies reported here showed that LL/2 tumor cell vaccine modified by a co-expressing mouse GM-CSF and IL-18 plasmid could significantly inhibit tumor growth and increased survival of the mice bearing LL/2 tumor whether prophylactic or adoptive immunotherapy in vivo. A significant reduction of proliferation and increase of apoptosis were also observed in the tumor treated with vaccine of co-expressing GM-CSF and IL-18. The potent antitumor effect correlated with higher secretion levels of pro-inflammatory cytokines such as IL-18, GM-CSF, interferon-γ in serum, the proliferation of CD4+ IFN-γ+, CD8+ IFN-γ+ T lymphocytes in spleen and the infiltration of CD4+, CD8+ T in tumor. Furthermore, the mechanism of tumor-specific immune response was further proved by 51Cr cytotoxicity assay in vitro and depletion of CD4, CD8, NK immune cell subsets in vivo. The results suggested that the antitumor mechanism was mainly depended on CD4+, CD8+ T lymphocytes.ConclusionsThese results provide a new insight into therapeutic mechanisms of IL-18 plus GM-CSF modified tumor cell vaccine and provide a potential clinical cancer immunotherapeutic agent for improved antitumor immunity.

Antitumor Effect Of Intravenous Immunization With Malaria Genetically Attenuated Sporozoites Through Induction Of Innate And Adaptive Immunity

Antitumor effect of malaria genetically attenuated sporozoites infection in a murine lewis lung cancer model

Antitumor Effect of Malaria Parasite Infection in a Murine Lewis Lung Cancer Model Through Induction of Innate and Adaptive Immunity

Attenuated Plasmodium Sporozoite Expressing MAGE-A3 Induces Antigen-Specific CD8+ T Cell Response Against Lung Cancer in Mice.

Inhibition of Tumor Angiogenesis in Lung Cancer by T4 Phage Surface Displaying Mvegfr2 Vaccine

[Antitumor Effect of Recombinant T7 Phage Vaccine Expressing Xenogenic Vascular Endothelial Growth Factor on Lewis Lung Cancer in Mice].

Plasmodium immunotherapy combined with gemcitabine has a synergistic inhibitory effect on tumor growth and metastasis in murine Lewis lung cancer models

Vaccination with Tcl Plus Mhsp65 Induces Anti-Lung Cancer Immunity in Mice

Vaccination With Allogeneic Gm-Csf Gene-Modified Lung Cancer Cells: Antitumor Activity Comparing With That Induced By Autologous Vaccine

Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects

A Novel PD-L1-Containing MSLN Targeting Vaccine Elicits Therapeutic Antitumor Immunity in Mice

Antitumor Effects Obtained by Autologous Lewis Lung Cancer Cell Vaccine Engineered to Secrete Mouse Interleukin 27 by Means of Cationic Liposome.

Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime

Antitumor Activity of Pluripotent Cell-Engineered Vaccines and Their Potential to Treat Lung Cancer in Relation to Different Levels of Irradiation

Preparation of murine lung cancer vaccine modified by macrophagic inflammatory protein 1αand observational study of antitumor activity in vivo

Antitumor effect of invasive Lactobacillus plantarum delivering associated antigen gene sHSP between Trichinella spiralis and Lewis lung cancer cells

Efficacy of 3LL/GM-CSF Tumor Vaccine Combined with Pacilitaxel Chemotherapy in Treatment of Mice Bearing Transplanted Lewis Lung Carcinoma

A Novel PD-L1-Containing MSLN Targeting Vaccine for Lung Cancer Immunotherapy

Antitumor Activity and Immunomodulatory Effects of the Intraperitoneal Administration of Kanglaite in Vivo in Lewis Lung Carcinoma

Superior Anti-Tumor Protection and Therapeutic Efficacy of Vaccination with Dendritic Cell/Tumor Cell Fusion Hybrids for Murine Lewis Lung Carcinoma